Allen Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.03M Sell
23,602
-1,593
-6% -$186K 1.48% 12
2026
Q1
$3.03M Buy
25,195
+434
+2% +$50.1K 1.52% 12
2025
Q4
$2.61M Sell
24,761
-871
-3% -$81.8K 1.57% 14
2025
Q3
$2.15M Buy
25,632
+2,002
+8% +$165K 1.46% 14
2025
Q2
$1.87M Sell
23,630
-4
-0% -$318 1.31% 17
2025
Q1
$2.12M Sell
23,634
-312
-1% -$29.1K 1.46% 13
2024
Q4
$2.38M Sell
23,946
-78
-0.3% -$8.04K 1.71% 10
2024
Q3
$2.73M Buy
24,024
+1,940
+9% +$230K 1.89% 10
2024
Q2
$2.73M Buy
22,084
+56
+0.3% +$7.21K 2.43% 7
2024
Q1
$2.91M Buy
22,028
+246
+1% +$30.3K 2.56% 6
2023
Q4
$2.37M Buy
+21,782
New +$2.26M 2.33% 10

Other funds holding MRK

Allen Wealth Management's MRK Position: Q2 2026 in Review

Allen Wealth Management reduced its Merck (MRK) stake by 6.3% in Q2 2026, selling an estimated $186K and leaving 23,602 shares worth $3.03M. The position accounts for 1.48% of the portfolio, ranked #12.

Allen Wealth Management first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. 1,778 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Allen Wealth Management held 23,602 shares of Merck worth $3.03M as of Q2 2026.
  • Allen Wealth Management sold 1,593 Merck shares in Q2 2026, an estimated $186K.
  • Merck made up 1.48% of Allen Wealth Management's portfolio in Q2 2026, its #12 holding.
  • Allen Wealth Management first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • 1,778 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Allen Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.